Search - tctmd.com

Displaying 61 - 80 of 126

Sort: Relevancy | Date

Presentation THT Abstracts 2024

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Presenter: Alexandra Steverson

March 05, 2024

Presentation THT 2024

RECOVER-HF Pilot Study: Synchronized Diaphragmatic Stimulation for HFrEF Therapy

Presenter: Marat Fudim

March 05, 2024

Presentation THT 2024

RESTORE Medical: Transcatheter Pulmonary Artery Banding for Patients With HFrEF

Presenter: Gilad Marom

March 05, 2024

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

Presentation THT Abstracts 2024

Vsling- Ventricular repair device for HFrEF patients

Presenter: Boaz Manash

March 04, 2024

Presentation THT Abstracts 2024

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Presenter: Carl Pepine

March 04, 2024

Presentation THT Abstracts 2024

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

Presenter: Marvin Konstam

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

Presentation TCT 2023

Transcatheter Pulmonary Artery Banding In Chronic Heart Failure [HFrEF]: Results From the First-in-Human Study

Presenter: Sean Pinney

October 26, 2023

Presentation TCT 2023

Moderate AS in HFrEF: Time to Treat Is Now

Presenter: Nicolas Van Mieghem

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair for Secondary MR in the Management of HFrEF: Where Does It Fit in?

Presenter: Marianna Adamo

October 24, 2023

Presentation TCT 2023

TCT 982: Invasive Provocative Spasm Testing and Microvascular Testing Revealed True Cause of HFrEF in a Patient with Suspected Sarcoidosis

Presenter: Edward Ha

October 24, 2023

Presentation TVT 2023

The Current Status of Interatrial Shunts for HFrEF and HFpEF (Importance of Hemodynamic Exercise Testing)

Presenter: Martin Leon

June 08, 2023

Presentation THT 2023

Long-term Outcomes of Endovascular Baroreflex Amplification in Symptomatic Patients With HFrEF

Presenter: JoAnn Lindenfeld

March 22, 2023

Presentation THT 2023

Longer Term Effects of Hemodynamic Monitoring on Outcomes: A Combined Data Analysis of Patients with HFrEF in CHAMPION, GUIDE-HF, and LAPTOP-HF

Presenter: JoAnn Lindenfeld

March 21, 2023

Presentation THT 2023

Splanchnic Nerve Denervation for HFrEF and HFpEF

Presenter: Marat Fudim

March 21, 2023

Presentation THT 2023

Cardiac Contractility Modulation for HFrEF and HFpEF: Impulse Dynamics

Presenter: Javed Butler

March 21, 2023

Presentation THT 2023

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

Presenter: Gregg Stone

March 21, 2023

Presentation THT 2023

MIRTH: Myocardial Intramural Remodeling by Transvenous Tether

Presenter: Adam Greenbaum

March 21, 2023

Presentation THT 2023

CardiacSuccess / V-Sling

Presenter: Horst Sievert

March 21, 2023

Advertisement

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

RECOVER-HF Pilot Study: Synchronized Diaphragmatic Stimulation for HFrEF Therapy

RESTORE Medical: Transcatheter Pulmonary Artery Banding for Patients With HFrEF

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Vsling- Ventricular repair device for HFrEF patients

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Transcatheter Pulmonary Artery Banding In Chronic Heart Failure [HFrEF]: Results From the First-in-Human Study

Moderate AS in HFrEF: Time to Treat Is Now

Mitral Transcatheter Edge-to-Edge Repair for Secondary MR in the Management of HFrEF: Where Does It Fit in?

TCT 982: Invasive Provocative Spasm Testing and Microvascular Testing Revealed True Cause of HFrEF in a Patient with Suspected Sarcoidosis

The Current Status of Interatrial Shunts for HFrEF and HFpEF (Importance of Hemodynamic Exercise Testing)

Long-term Outcomes of Endovascular Baroreflex Amplification in Symptomatic Patients With HFrEF

Longer Term Effects of Hemodynamic Monitoring on Outcomes: A Combined Data Analysis of Patients with HFrEF in CHAMPION, GUIDE-HF, and LAPTOP-HF

Splanchnic Nerve Denervation for HFrEF and HFpEF

Cardiac Contractility Modulation for HFrEF and HFpEF: Impulse Dynamics

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

MIRTH: Myocardial Intramural Remodeling by Transvenous Tether

CardiacSuccess / V-Sling

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content